Showing results (661-670 of 744) with videos related to
Sort By:
Pageof 75
European Urology|July 19, 2018
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective TrialLaurence Klotz, Andrew Loblaw, Linda Sugar, et al.The Prostate|April 19, 2019
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cellsThiago Vidotto, Fabiano P Saggioro, Tamara Jamaspishvili, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2014
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomyTamara L Lotan, Filipe Lf Carvalho, Sarah B Peskoe, et al.The Journal of Urology|April 22, 2014
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsiesAlan W Partin, Leander Van Neste, Eric A Klein, et al.Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.The American Journal of Surgical Pathology|August 19, 2010
Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologistsAnkur R Sangoi, Andrew H Beck, Mahul B Amin, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohortsStephanie A Harmon, Palak G Patel, Thomas H Sanford, et al.British Journal of Cancer|April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patientsWalead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.Cancer Immunology Research|June 25, 2024
Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non-Muscle Invasive Bladder CancerPriyanka Yolmo, Sadaf Rahimi, Stephen Chenard, et al.The American Journal of Surgical Pathology|July 19, 2017
Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3?Jennifer Gordetsky, Joseph Sanfrancesco, Jonathan I Epstein, et al.Pageof 75